Skip to main content
Clinical Trials/CTRI/2020/05/025350
CTRI/2020/05/025350
Not yet recruiting
Phase 2

Observational study to assess safety and efficacy of Inj Sepsivac in patients of Covid-19 at R D Gardi Medical College, Ujjain, India

R D Gardi Medical College0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
R D Gardi Medical College
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients between the age of 18 â?? 65 years diagnosed to have Covid19 infection confirmed by RTPCR assay,
  • any one or more of the following
  • 1\. Either an oxygen saturation of 94% or less while the patient was breathing ambient air or a need for oxygen support
  • 2\. Creatinine clearance above 30 ml per minute
  • 3\. Serum levels of ALT and AST less than five times the upper limit of the normal range
  • 4\. Requirement of vasopressor

Exclusion Criteria

  • 1\.Pregnant or nursing female.
  • 2\.Patient previously enrolled into similar study.
  • 3\.Patient participating or having participated in a clinical trial with another investigational drug within the last 28 days except for investigational drugs against cancer, leukaemia or HIV.
  • 4\.Patients not likely to complete the trial as per judgment of the investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials